The DOI matches its Crossref record; 157 of the 158 references it cites were found in a registry or an index.
Liver inflammation and fibrosis
Open accessAbstract
Chronic liver inflammation leads to fibrosis and cirrhosis, which is the 12th leading cause of death in the United States. Hepatocyte steatosis is a component of metabolic syndrome and insulin resistance. Hepatic steatosis may be benign or progress to hepatocyte injury and the initiation of inflammation, which activates immune cells. While Kupffer cells are the resident macrophage in the liver, inflammatory cells such as infiltrating macrophages, T lymphocytes, neutrophils, and DCs all contribute to liver inflammation. The inflammatory cells activate hepatic stellate cells, which are the major source of myofibroblasts in the liver. Here we review the initiation of inflammation in the liver, the liver inflammatory cells, and their crosstalk with myofibroblasts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A key event in liver fibrogenesis is the activation of quiescent HSCs, which differentiate into myofibroblasts and secrete large amounts of collagen and profibrosis factors.( 71 )”
From The Emerging Role of B Cells in the Pathogenesis of NAFLD (2021) · cites this paper as [71]
In the citing paper
“A key event in liver fibrogenesis is the activation of quiescent HSCs, which differentiate into myofibroblasts and secrete large amounts of collagen and profibrosis factors.( 71 )”
From The Emerging Role of B Cells in the Pathogenesis of NAFLD (2021) · cites this paper as [71]
In the citing paper
“Hepatic stellate cells (HSCs) play pivotal roles in the pathological development of liver fibrosis27.”
From SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis (2020) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,730
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Mizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Self-citationDevelopment of Monocytes, Macrophages, and Dendritic Cells
Geissmann, F., Manz, M. G., Jung, S., Sieweke, M. H., Merad, M., & Ley, K. (2010) · Science · doi:10.1126/science.1178331 · Cited by 3,049
Vrieze, A., Van Nood, E., Holleman, F., Salojärvi, J., Kootte, R. S., Bartelsman, J. F. W. M., Dallinga–Thie, G. M., Ackermans, M. T., Serlie, M. J., Oozeer, R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.031 · Cited by 2,913
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Schulz, C., Perdiguero, E. G., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E. W., Pollard, J. W., et al. (2012) · Science · doi:10.1126/science.1219179 · Cited by 2,578
Cited by
Sorted by citations
Items 601–700 of 1,000
Elmorsy, E. A., Saber, S., Hamad, R. S., Abdel‐Reheim, M. A., Nadwa, E. H., Alibrahim, A., Alkhamiss, A. S., Alsalloom, A. A., Mohamed, E. A. K., Nour-El-Din, M., et al. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122966 · Cited by 14
Renu, K., Gopalakrishnan, A. V., & Madhyastha, H. (2024) · Odontology · doi:10.1007/s10266-024-01032-x · Cited by 20
“Clinical treatments should benefit from an improved knowledge of the mechanisms driving inflammation [115].”
Immune Checkpoints and the Immunology of Liver Fibrosis
Tsomidis, I., Voumvouraki, A., & Kouroumalis, E. (2025) · Livers · doi:10.3390/livers5010005 · Cited by 14
Fibrosis and the intestinal microbiome; a focus on chronic liver disease
Beraza, N. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.09.012 · Cited by 14
Immunomodulatory effects of chicken cathelicidin-2 on a primary hepatic cell co-culture model
Sebők, C., Walmsley, S., Tráj, P., Mackei, M., Vörösházi, J., Petrilla, J., Kovács, L. Á., Kemény, Á., Neogrády, Z., & Mátis, G. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275847 · Cited by 14
“This is a major issue in livestock production because it can negatively affect animal welfare and decrease productivity [9].”
BackgroundBariatric surgery for diabetic comorbidities: A focus on hepatic, cardiac and renal fibrosis
Ding, H., Zhang, Y., Ma, X., Zhang, Z., Xu, Q., Liu, C., Li, B., Dong, S., Li, L., Zhu, J., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1016635 · Cited by 16
“Simultaneously, hepatocyte stress and death also promote inflammation, leading to macrophage recruitment and secretion of fibrotic-derived mediators, such as transforming growth factor beta (TGF-β), which is central to the liver fibrotic response (Koyama and Brenner, 2017; Tsuchida and Friedman, 2017).”
BackgroundMacrophage‐derived HMGB1 is dispensable for tissue fibrogenesis
Personnaz, J., Piccolo, E. B., Branchereau, M., Filliol, A. A., Paccoud, R., Moreau, E., Calise, D., Riant, É., Gourdy, P., Heymes, C., et al. (2019) · FASEB BioAdvances · doi:10.1096/fba.2018-00035 · Cited by 13
Ruoß, M., Rebholz, S., Weimer, M., Grom-Baumgarten, C., Athanasopulu, K., Kemkemer, R., Käß, H., Ehnert, S., & Nussler, A. K. (2020) · Journal of Functional Biomaterials · doi:10.3390/jfb11010017 · Cited by 14
“It might be useful to develop an in vitro model system that represents other aspects of liver fibrosis pathology, such as the change in ECM composition, oxygen tension, or inflammation [6,54,55].”
BackgroundYashaswini, C. N., Cogliati, B., Qin, T., To, T., Williamson, T., Papp, T. E., Li, K., Rasul, R., Chen, L., Lightstone, A., et al. (2025) · doi:10.1101/2025.02.25.640143 · Cited by 13
LEADS – a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing
Balachander, G. M., Ng, I. C., Pai, R. R., Mitra, K., Tasnim, F., Lim, Y. S., Kwok, R., Song, Y., Yaw, L. P., Quah, C. B., et al. (2025) · Lab on a Chip · doi:10.1039/d5lc00221d · Cited by 16
Hepatic Myofibroblasts: A Heterogeneous and Redox-Modulated Cell Population in Liver Fibrogenesis
Bocca, C., Protopapa, F., Foglia, B., Maggiora, M., Cannito, S., Parola, M., & Novo, E. (2022) · Antioxidants · doi:10.3390/antiox11071278 · Cited by 14
Anwar, W. S., Abdel‐Maksoud, F. M., Sayed, A. M. M., Abdel-Rahman, I. A. M., Makboul, M. A., & Zaher, A. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-03853-9 · Cited by 13
“They exhibit markers such as M1-like macrophages or M2-like macrophages that regulate liver inflammation [7].”
BackgroundInfluentialAzamov, B., Lee, K. M., Hur, J., Muradillaeva, S., Shim, W.-S., Lee, C., & Song, P. (2023) · Molecules · doi:10.3390/molecules28134971 · Cited by 13
“Although there is a strong relationship between fibrosis and inflammation [29], the potential effects of oxoglaucine on hepatic fibrosis, and the cellular mechanism by which oxoglaucine exerts its effect in murine hepatocytes, remain unclear.”
BackgroundKong, D., Mourtzinos, A., Heegsma, J., Blokzijl, H., de Meijer, V. E., & Faber, K. N. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03493-3 · Cited by 14
“Inflammation and hepatic fibrosis therefore co-exist in chronic liver diseases [32].”
BackgroundKhan, M. A., Fischer, J., Harrer, L., Schwiering, F., Groneberg, D., & Friebe, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-69898-z · Cited by 13
New Onset of Acute and Chronic Hepatic Diseases Post-COVID-19 Infection: A Systematic Review
Lebbe, A. A., Aboulwafa, A., Bayraktar, N., Mushannen, B., Ayoub, S., Sarker, S., Abdalla, M. N., Mohammed, I., Mushannen, M., Yagan, L., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12092065 · Cited by 13
“This inflammation is the body’s natural response to injury or infection [42].”
BackgroundSong, X., Sun, J., Yue, Y., Li, D., & Chen, F. (2024) · Food Research International · doi:10.1016/j.foodres.2024.115123 · Cited by 15
Peirovy, Y., & Asle‐Rousta, M. (2024) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14618 · Cited by 13
“Chemotactic cytokines guide these cells, and their infiltration eventually leads to stellate cell activation and an increase in transforming growth factor-beta expression, which can cause liver fibrosis (Karlmark et al. 2008; Koyama and Brenner 2017).”
Huang, W., Zhou, X., Fu, G., Ding, M., Wu, H., Zeng, M., Zhang, H., Xu, L., Gao, Y., Wang, H., et al. (2021) · Theranostics · doi:10.7150/thno.54457 · Cited by 13
“Despite the fact that hepatic stellate cells (HSCs) play a pivotal role in liver fibrosis, mature hepatocytes (MHs) are dominant cell type residing in the liver and their damage is commonly recognized as the key initiator of fibrosis by releasing pro-inflammatory factors to activate HSCs [3].”
BackgroundAntifibrotic and anthelminthic effect of casticin on Schistosoma mansoni-infected BALB/c mice
Lam, H. Y. P., Liang, T.-R., Lan, Y.-C., Chang, K., Cheng, P.-C., & Peng, S.-Y. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.03.017 · Cited by 13
Inflammatory and Non-Inflammatory Mechanisms Controlling Cirrhosis Development
Sánchez, P. S., Rigual, M. D. M., & Djouder, N. (2021) · Cancers · doi:10.3390/cancers13205045 · Cited by 13
“The inflammation response involves the secretion of chemokines, cytokines and other factors [32,33] responsible for the activation, proliferation, migration and differentiation of HPCs and/or HSCs [34].”
BackgroundLiao, Y., Gong, J., Zhou, W., Dong, H., Liang, J., Luo, M., & Hu, B. (2018) · Journal of Medical Virology · doi:10.1002/jmv.25364 · Cited by 13
“Active significant liver inflammation is the leading cause of fibrosis and cirrhosis in patients with CHB.18 Thus, the detection of the initial stage of liver inflammation is the priority for the control of liver cirrhosis.”
BackgroundInfluentialAntifibrotic effects of total or partial application of amniotic membrane in hepatic fibrosis
MAMEDE, K. M., & Sant’Anna, L. B. (2019) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201920190220 · Cited by 13
Chang, H., Ni, Y., Shen, C., Li, C., He, K., Zhu, X., Chen, L., Chen, L., Qiu, J., Ji, Y., et al. (2022) · Immunology · doi:10.1111/imm.13519 · Cited by 12
“Regulatory T (Treg) cells are a group of heterogeneous CD4 T cells, usually coexpress CD25 and transcription factor forkhead box protein 3 (Foxp3), play vital roles in the regulation of hepatic diseases, including hepatitis [18], alcoholic fatty liver [19], and liver fibrosis [20].”
BackgroundLallement, J., Raho, I., Merlen, G., Rainteau, D. P., Croyal, M., Schiffano, M., Kassis, N., Doignon, I., Soty, M., Lachkar, F., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159333 · Cited by 12
“As inflammation, which could be triggered by unbalanced Cer proportions, is known to be associated with liver disorders [36,37], we assessed inflammatory response activation through the presence of granulocyte receptor-1 ( Gr-1 ) positive cells in frozen liver tissue sections.”
BackgroundProtective Effects of Phytic Acid on CCl4-Induced Liver Fibrosis in Mice
Xu, Z., Zhao, C., Lan, T., Han, Y., Yang, N., Wang, C., Tao, M., Li, H., Song, Y., & Ma, X. (2023) · Journal of Food Biochemistry · doi:10.1155/2023/6634450 · Cited by 13
Metabolic characteristics of voriconazole – Induced liver injury in rats
Du, Q., Teng, M., Yang, L., Meng, C., Qiu, Y., Wang, C., Chen, J., Wang, T., Chen, S., Luo, Y., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110693 · Cited by 12
Redox Biology and Liver Fibrosis
Bellanti, F., Mangieri, D., & Vendemiale, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010410 · Cited by 12
“Indeed, fibrogenic liver injury is triggered and perpetuated by Kupffer cells (KCs), bone marrow-derived macrophages, and neutrophils, which release cytokines, chemokines, and growth factors with a critical role in the pathogenesis of fibrosis [6].”
BackgroundWang, C., Zhang, S., Li, Y., Gong, L., Yao, C., Fu, K., & Li, Y. (2024) · Inflammation · doi:10.1007/s10753-024-01984-w · Cited by 12
“Subsequently, the increased levels of pro-inflammatory cytokines further promote the activation and proliferation of HSCs, allowing the synthesis of large amounts of ECM, which in turn accelerates the progression of HF [31, 32].”
Wu, Z., Liu, D., Ou, Y., Xu, Z., Heng, G., Liu, W., Fu, N., Wang, J., Jiang, D., Gan, L., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1622 · Cited by 11
“39,40 Several studies have indeed shown that LT recipients have a higher incidence of metabolic syndrome, insulin resistance, and dyslipidemia than the general population.”
BackgroundMechanism of PANoptosis in metabolic dysfunction-associated steatotic liver disease
Ni, K., & Meng, L. (2024) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2024.102381 · Cited by 14
Yang, B., Lu, L., Xiong, T., Fan, W., Wang, J., Barbier‐Torres, L., Chhimwal, J., Sinha, S., Tsuchiya, T., Mavila, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52527-8 · Cited by 13
Yan, L., Zhang, X., Fu, J., Liu, Q., Lei, X., Cao, Z., Zhang, J., Shao, Y., Tong, Q., Qin, W., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.04.065 · Cited by 12
Khalil, H. E., Ibrahim, H.-I. M., El-Fass, K. A., Akrawi, S. H., & Morsy, M. A. (2022) · Applied Sciences · doi:10.3390/app12052725 · Cited by 12
“Worldwide, more than 1 million deaths each year are due to the chronic liver inflammation associated with fibrosis and cirrhosis [4].”
BackgroundQiu, J., Chai, Y.-N., Duan, F.-Y., Zhang, H., Han, X.-Y., Chen, L., & Duan, F. (2022) · Acta Biochimica Polonica · doi:10.18388/abp.2020_5802 · Cited by 13
The hepatic extramedullary hematopoiesis during experimental murine Schistosomiasis mansoni
Francisco, J. S., Terra, M. A. B. L., Klein, G. C. T., de Oliveira, B. C. E. P. D., & Pelajo‐Machado, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955034 · Cited by 12
“These macrophage progenitors can be responsible for the local proliferation of the Kupffer cells in some cases, like inflammatory events (19, 20).”
BackgroundZhao, R., Zhao, H., Guo, Q., Mu, Y., Zhang, J., Su, Y., & Han, Q. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110251 · Cited by 12
Hirao, H., Ito, T., Kadono, K., Kojima, H., Naini, B. V., Nakamura, K., Kageyama, S., Busuttil, R. W., Kupiec‐Weglinski, J. W., & Kaldas, F. M. (2021) · Hepatology · doi:10.1002/hep.32030 · Cited by 12
Li, X., Peng, W.-T., Shan, S., Wu, J., Li, N., Du, J., Sun, J.-C., Chen, T., Wei, W., & Sun, W. (2021) · Journal of Cancer · doi:10.7150/jca.59291 · Cited by 12
“It has been reported that the inflammatory cells such as T lymphocytes activate HSCs, which are the major source of myofibroblasts in the liver [42].”
BackgroundLu, Y., Chang, N., Zhao, X., Xue, R., Liu, J., Yang, L., & Li, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.824385 · Cited by 12
Xue, S., Zhu, Y., Shao, M., Zhu, K., Rong, J., Liu, T., Yin, X., Zhang, S., Yin, L., & Wang, X. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-03701-9 · Cited by 11
Interactions between hepatic stellate cells and immune cells: Implications for liver fibrosis
Xie, D., Huang, Y., Yu, Y., Jin, W., Zhang, X., & Yu, F. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168062 · Cited by 12
Bengel, F. M., Hess, A., Diekmann, J., & Thackeray, J. T. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-025-01242-y · Cited by 13
“The crossover of inflammation and fibroblast activation transcends the myocardium, and similar processes have been identified in lung disease 118 , chronic liver disease 119 and renal failure 120 , independent of cardiovascular injury.”
Lipocalin 2 Is a Regulator During Macrophage Polarization Induced by Soluble Worm Antigens
Shen, H., Wang, Z., Huang, A., Zhu, D., Sun, P., & Duan, Y. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.747135 · Cited by 11
Ruan, L., Jiang, L., Zhao, W., Meng, H., Zheng, Q., & Wang, J. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2021.115734 · Cited by 11
Sun, X., Yu, Q., Kang, B., Zhao, X., Li, H., Liu, H., Liu, L., Wang, P., Cong, M., & Liu, T. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.12.039 · Cited by 11
Li, W., Zhang, L., Li, Y.-Y., Wang, X., Li, J.-L., Zhao, S.-N., Ni, M.-Q., Li, Q., & Sun, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010670 · Cited by 12
“Macrophages mobilize neutrophils to the site of liver injury, thus amplifying proinflammatory reactions and liver damage [44].”
BackgroundThe anti-fibrotic efficacy of adelmidrol depends on hepatic PPARγ levels
Xiang, H., Xiao, J., Sun, Z., Liu, Z., Zhang, J., Xiang, H., Ren, H., Hu, P., & Peng, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115051 · Cited by 11
Ohene-Marfo, P., Nguyen, H. V. M., Mohammed, S., Thadathil, N., Tran, A., Nicklas, E. H., Wang, D., Selvarani, R., Farriester, J. W., Varshney, R., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052813 · Cited by 12
“Hepatocyte injury, inflammation, and the innate immune system promote liver fibrosis through the activation of hepatic stellate cells and the secretion and deposition of extracellular matrix [32].”
BackgroundA role for curcumin in preventing liver fibrosis in animals: a systematic review and meta-analysis
Huang, B.-H., Guo, Z., Lv, B., Zhao, X., Li, Y., & Lv, W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1396834 · Cited by 14
Inhibition of CCl4-induced liver inflammation and fibrosis by a NEU3 inhibitor
Pilling, D., Martinez, T. C., & Gomer, R. H. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308060 · Cited by 10
“These data suggest that, as expected [5, 55, 56], there is a link between inflammation and fibrosis in liver disease.”
InfluentialJia, H., Li, J., Chen, X., Liu, Z., Wu, C., Liu, C., Zhang, J., Luo, M., Huang, M., Huang, S., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156489 · Cited by 11
Xu, Q.-Y., Ren, T., Zhou, Y.-C., Xu, J., Du, L.-D., Hong, D.-Y., Zhang, Q., Chu, H., Peng, Z., Fan, J., et al. (2025) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2025.02.004 · Cited by 11
Kallikourdis, M., Cochran, J. D., Walsh, K. X., & Condorelli, G. (2025) · Circulation Research · doi:10.1161/circresaha.125.325489 · Cited by 12
Role and mechanisms of cuproptosis in the pathogenesis of Wilson's disease (Review)
Chen, H., Wang, X., Jin, X., Pu, Y., Ye, H., Ma, Y., & Zhang, J. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5558 · Cited by 15
Qin, T., Qin, L., Zhao, Y., Chen, Y., Liu, Q., Lin, X., Lan, Y., Huang, Y., Liu, Y., Zhang, K., et al. (2025) · Advanced Science · doi:10.1002/advs.202417252 · Cited by 11
The role of ADAM17 during liver damage
Al-Salihi, M. A., Bornikoel, A., Zhuang, Y., Stachura, P., Scheller, J., Lang, K. S., & Lang, P. A. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0149 · Cited by 11
“…by viral infections, alcoholic and non-alcoholic liver disease, as well as auto-immune diseases affecting the liver or bile duct, hepatic in fl ammation and injury can result in liver fi brosis, cirrhosis, and even hepatocellular carcinoma (Byass 2014; Iwaisako et al. 2014; Koyama and Brenner 2017).”
InfluentialRaj, D., Sharma, V., Upadhyaya, A., Kumar, N., Joshi, R., Acharya, V., Kumar, D., & Patial, V. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114741 · Cited by 11
Liu, L., Liu, Z., Meng, L., Li, L., Gao, J., Yu, S., Hu, B., Yang, H., Guo, W., & Zhang, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.766609 · Cited by 11
“Fibrosis is a highly dynamic process and is associated with spatiotemporal regulation, the involvement of multiple carcinogenic signaling pathways, and the interaction of inflammation (Koyama and Brenner, 2017; Henderson et al., 2020).”
BackgroundInfluentialYaghoubi, A., Azarpira, N., Karbalay‐Doust, S., Daneshi, S., Vojdani, Z., & Talaei‐Khozani, T. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02711-8 · Cited by 12
“Hintermann E, Bayer M, Pfeilschifter JM, Luster AD, Christen U. CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation.”
BackgroundInfluentialRoles of heterogenous hepatic macrophages in the progression of liver diseases
Lee, K., Kim, M., & Han, Y. (2022) · BMB Reports · doi:10.5483/bmbrep.2022.55.4.022 · Cited by 12
“Disorders of hepatocyte metabolism and other nonparenchymal cells including macrophages cause development of hepatic inflammation and fibrosis which lead to steatohepatitis and cirrhosis (2, 3).”
BackgroundInhibition of P2Y6 receptor expression in Kupffer cells alleviates alcoholic steatohepatitis in mice
Yuan, F., Cai, J.-N., Dai, M., & Lv, X. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108909 · Cited by 11
Sun, R., Xiang, Z., & Wu, B. (2022) · Portal hypertension & cirrhosis · doi:10.1002/poh2.11 · Cited by 12
Yan, F., Qian, H., Liu, F., Ding, C., Liu, S., Xiao, M., Chen, S., Zhang, X., Luo, C., & Xie, W. (2022) · The FASEB Journal · doi:10.1096/fj.202200238r · Cited by 11
Chowdhury, O., Ghosh, S., Das, A., Liu, H., Shang, P., Stepicheva, N. A., Hose, S., Sinha, D., & Chattopadhyay, S. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110521 · Cited by 11
Suk, F., Hsu, F.-Y., Lee, Y., Chen, T.-L., Chiu, W., & Liao, Y. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109267 · Cited by 10
Azar, K. A. H. M., Ezhilarasan, D., Harini, K. S., Karthick, M., & Mani, U. (2023) · Cell Biochemistry and Function · doi:10.1002/cbf.3839 · Cited by 11
“10 Among numerous inflammatory mediators, nuclear factor κ B (NF ‐ κ B) plays a prominent role in the transcriptional regulation of pro ‐ inflammatory genes in the liver.”
Nithyananthan, S., & Thirunavukkarasu, C. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29037 · Cited by 11
Wen, J., Wang, D., Wang, J., Wang, R., Wei, S., & Zhao, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5574010 · Cited by 11
“It has been reported that HSCs activated by inflammatory factors are the main source of myofibroblasts in the liver [34].”
BackgroundShi, C., Wang, Y., Jiao, F., Chen, Q., Cao, P., Pei, M., Zhang, L., Guo, J., Deng, W., Wang, L.-W., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.683526 · Cited by 11
“The activation of HSC comes from the inflammatory activity of liver immune cells, mainly macrophages (Koyama and Brenner, 2017).”
BackgroundOprić, D., Stanković, A., Nenadović, A., Kovačević, S., Obradović, D. D., Luka, S. R. D., Ostojić, J. N., Milašin, J., Ilić, A. Ž., & Trbovich, A. M. (2020) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2020.101959 · Cited by 11
Wang, Z., Qian, J., Lu, X., Zhang, P., Guo, R., Lou, H., Zhang, S., Yang, J., & Fan, X. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.06.451396 · Cited by 11
“After activation, KCs 60 adopt M1-like pro-inflammatory macrophage or M2-like anti-inflammatory 61 macrophage functions in response to liver injury (3).”
BackgroundInfluentialComprehensive study of the murine MASH models' applicability by comparing human liver transcriptomes
Ning, M., Lu, D., Teng, B., Liang, D., & Ren, P. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123723 · Cited by 10
Role of persistent necroinflammation in chronic tissue remodeling and organ fibrosis
More, S. A., Ghosh, A., Kulkarni, O. P., & Mulay, S. R. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00416.2025 · Cited by 11
Kohara, S., & Ogawa, K. (2022) · Biomedicines · doi:10.3390/biomedicines10123234 · Cited by 10
“Chronic inflammation in the liver leads to fibrosis, in which Kupffer cells and recruited Mø are involved in the activation of hepatic stellate cells and fibrosis progression [31,32].”
BackgroundHepatocellular Brg1 promotes CCl4-induced liver inflammation, ECM accumulation and fibrosis in mice
Wang, B., Kaufmann, B. K., Mogler, C., Zhong, S., Yin, Y., Cheng, Z., Schmid, R. M., Friess, H., Hüser, N., von Figura, G., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294257 · Cited by 10
Autophagy modulates physiologic and adaptive response in the liver
Le, T. V., Truong, N. H., & Holterman, A. (2023) · Liver Research · doi:10.1016/j.livres.2023.12.001 · Cited by 13
Wen, T., Xie, J., Ma, L., Hao, Z., Zhang, W., Wu, T., & Li, L. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.11.016 · Cited by 10
Zhang, Y. Q., Huang, H., Luo, C., Zhang, X., Chen, Y., Yue, F., Xie, B., Chen, T., & Zou, C. (2024) · Nutrients · doi:10.3390/nu16101468 · Cited by 10
“Liver injury is a prevalent pathology featuring massive necrosis of hepatocytes, leading to a dramatic decline in liver function, and is responsible for more than 1 million deaths worldwide each year [1,2].”
BackgroundKim, H., Jeon, H.-J., Kim, D., Kim, J.-Y., Shim, J.-J., & Lee, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189870 · Cited by 11
“This liver inflammation is an important precursor to liver fibrosis in NAFLD [52].”
BackgroundDing, C., Liu, B., Yu, T., Wang, Z., Peng, J., Gu, Y., & Li, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117477 · Cited by 12
Zhu, A., Yan, X., Chen, M., Lin, Y., Li, L., Wang, Y., Huang, J., He, J., Yang, M., Hua, W., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156341 · Cited by 10
Li, P., Zhang, R., Hu, P., Wang, T., & Wang, J. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119358 · Cited by 10
Astragaloside IV prevents liver fibrosis by blocking glycolysis-mediated macrophage M1 polarization
Hu, Y., Kuang, M., Song, H., Tan, Y., Zhou, F., Pei, G., & Jiao, L. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177353 · Cited by 11
Sabini, J. H., & Timotius, K. H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47030159 · Cited by 12
“These mediators profoundly affect HSCs, influencing essential processes such as proliferation, migration, and differentiation, promoting liver fibrosis [89,90].”
Liu, W., Li, X., Chen, L., & Luo, X. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01891-7 · Cited by 10
A comprehensive molecular atlas of the mesenchymal cell types in the mouse liver
Pietilä, R. S., Genové, G., Mocci, G., Miao, Y., Liu, J., Leptidis, S., Gaudio, F. D., Uhrbom, M., Vázquez-Liébanas, E., Gustafsson, S., et al. (2025) · EMBO Reports · doi:10.1038/s44319-025-00580-9 · Cited by 18
O’Brien, A., Zhou, T., White, T. K., Medford, A., Chen, L., Kyritsi, K., Wu, N., Childs, J. R., Stiles, D., Ceci, L., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1909 · Cited by 12
Gao, C., Cai, X. M., Lymbery, A. J., Ma, L., Cao, M., & Li, C. (2023) · Aquaculture · doi:10.1016/j.aquaculture.2023.739320 · Cited by 11
The association of in-utero exposure to polycyclic aromatic hydrocarbons and umbilical liver enzymes
Li, W., Okromelidze, M. T., Ramírez‐Coronel, A. A., Zekiy, A. O., Obaid, R. F., Jawhar, Z. H., Gabr, G. A., Al‐Hamdani, M. M., Kadhim, S. I., Mustafa, Y. F., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.164220 · Cited by 10
Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury
Sommer, J., Dorn, C., Gäbele, E., Bataille, F., Freese, K., Seitz, T., Thasler, W. E., Büttner, R., Weiskirchen, R., Bosserhoff, A., et al. (2020) · Cells · doi:10.3390/cells9010248 · Cited by 10
“The activation of hepatic stellate cells (HSCs) is the key event of hepatic fibrosis [2,3].”
BackgroundTwenty-four-week oral dosing toxicities of Herba Siegesbeckiae in rats
Wu, J., Chan, Y.-C., Guo, H., Chen, Y., Liu, Y., Hua, Y., & Yu, Z. (2020) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-020-03137-6 · Cited by 10
Pilling, D., Karhadkar, T. R., & Gomer, R. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0244762 · Cited by 11
“These processes are inflammatory and lead to the activation of the tissue resident liver macrophages (Kupffer cells) as well as a recruitment of a variety of circulating immune cells (inflammation) [10, 13, 14].”
Han, M., Geng, J., Zhang, S., Rao, J., Zhu, Y., Xu, S., Wang, F., Ma, F., Zhou, M., & Zhou, H. (2023) · European Journal of Immunology · doi:10.1002/eji.202350474 · Cited by 12
“The inflammatory response of the liver is a crucial driving force that promotes the transition from NAFLD to nonalcoholic steato-hepatitis (NASH) by inducing a persistent state of liver fibrosis, ultimately leading to cirrhosis [2].”
BackgroundTsang, H. Y., Lo, P. H. Y., & Lee, K. K. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.29.450347 · Cited by 10
Aging-associated inflammation and fibrosis in arachnoid membrane
Suzuki, H., Mikami, T., Iwahara, N., Akiyama, Y., Wanibuchi, M., Komatsu, K., Yokoyama, R., Hirano, T., Hosoda, R., Horio, Y., et al. (2021) · BMC Neurology · doi:10.1186/s12883-021-02202-y · Cited by 8
Kermanizadeh, A., Jacobsen, N. R., Mroczko, A., Brown, D., & Stone, V. (2021) · Nanotoxicology · doi:10.1080/17435390.2021.2020350 · Cited by 10
Lai, Y., Sung, Y., Lai, Y.-A., Chen, L.-N., Chen, T., & Chien, C. (2022) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-022-00472-2 · Cited by 9
“have shifted from viral infections to metabolic problems such as alcoholic hepatitis or non-alcoholic steatohepatitis [2, 3].”
BackgroundLPS-Induced Liver Injury of Magang Geese through Toll-like Receptor and MAPK Signaling Pathway
Li, B.-X., Hong, L., Luo, Y.-D., Zhang, B., Yu, Z.-Y., Li, W.-Y., Cao, N., Huang, Y.-M., Xu, D.-N., Li, Y., et al. (2022) · Animals · doi:10.3390/ani13010127 · Cited by 9
“The accumulation of inflammation can further lead to liver damage [44].”
BackgroundHigashioka, M., Hirakawa, Y., Hata, J., Honda, T., Sakata, S., Shibata, M., Kitazono, T., Osawa, H., & Ninomiya, T. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad011 · Cited by 9
Metadata
- Authors
- Koyama, Y., & Brenner, D. A.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Brenner, David A.
- Venue
- Journal of Clinical Investigation
- Published
- 2017-01-03
- Volume
- 127
- Issue
- 1
- Pages
- 55-64
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5199698
- OpenAlex
- W2562949639
- Cited by
- 1,295
- References
- 158
- Citations by year
- 2026: 139 · 2025: 162 · 2024: 159 · 2023: 171 · 2022: 173 · 2021: 177 · 2020: 151 · 2019: 85 · 2018: 63 · 2017: 13
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health (ES010337, AA011999)
- National Institute on Alcohol Abuse and Alcoholism (U01AA021856, P50AA011999)
- National Institute of Environmental Health Sciences (P42ES010337)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- liver inflammation, liver fibrosis, liver cirrhosis, hepatic steatosis, Kupffer cells, hepatic stellate cells, myofibroblasts, immune cell crosstalk, T cells, neutrophils, dendritic cells, metabolic syndrome, insulin resistance
- MeSH terms
- Animals, Dendritic Cells, Hepatitis, Humans, Inflammation, Kupffer Cells, Liver, Liver Cirrhosis, Neutrophils, T-Lymphocytes, Hepatic Stellate Cells, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review